Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone in Children with Conduct Disorder and Mental Retardation
NCT00266552Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in conduct disorder (CD), oppositional defiant disorder (ODD), Disruptive behavior disorders (DBD), sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
risperidone
03
Conditions
conduct disorder (CD)oppositional defiant disorder (ODD)Disruptive behavior disorders (DBD)
Beyond the preview
Go deeper on NCT00266552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266552.